FrancophonIA/ELRC3.0 huggingface dataset:
English: The workload on RMPs will be considerable in the post-authorisation phase, taking into account the need for updates of RMPs agreed at the time of authorisation.
Slovenian: Načrti za obvladovanje tveganja bodo precej povečali delovno obremenitev, predvsem na stopnji po izdaji dovoljenj, če upoštevamo potrebo po spremembah teh načrtov, za katere so se dogovorili ob izdaji dovoljenja.
English: 16-18 May
Slovenian: 16.-18. maja
English: Scientific opinions for non-EU markets Similar biological products Generic and essentially similar products Compassionate-use products
Slovenian: Zdravila za sočutno uporabo Generična in bistveno podobna zdravila Zdravila s podobnimi biološkimi latnostmi Znanstvena mnenja za trge zunaj EU Zdravila sirote
English: 8-9 March
Slovenian: 8.-9. marca
English: Total Title 2
Slovenian: Naslov 2 skupaj
English: 18-20 July
Slovenian: 18.-20. julija
English: Arbitrations and referrals
Slovenian: Arbitraža in predložitve
English: Secure and reliable communication within the EU regulatory network is assured through EudraNet and the infrastructure supporting the systems.
Slovenian: EudraNet in infrastruktura, ki podpira sisteme, zagotavlja varno in zanesljivo komunikacijo v zakonodajnem okviru EU.
English: 24-27 July
Slovenian: 24.-27. julija
English: EMEA establishment plan 2004-2006
Slovenian: Načrt delovnih mest EMEA za obdobje 2004-2006
English: Establishment of maximum residue limits for veterinary medicines Post-authorisation activities
Slovenian: Določitev mejne vrednosti ostankov za veterinarska zdravila Dejavnosti po izdaji dovoljenja
English: 20-23 March
Slovenian: 20.-23. marca
English: 25-26 October
Slovenian: 25.-26. oktobra
English: The peer-review process of the first phase of assessment will be strengthened and monitored.
Slovenian: Okrepil in spremljal se bo postopek medsebojnih pregledov.
English: In addition to 33 core data elements, product information (SPC, PIL, labels) will be included in the database for a subset of centrally authorised products.
Slovenian: Za podskupino izdelkov, odobrenih po centraliziranem postopku, bodo v zbirko podatkov poleg 33 osnovnih elementov podatkov vključene še informacije o izdelkih (Povzetek glavnih značilnosti zdravila, Navodila za uporabo, nalepke).
English: Scientific-advice requests received/forecast (veterinary medicines)
Slovenian: Prejeti/predvideni zahtevki za znanstveno svetovanje (Veterinarska zdravila)
English: 24-27 April
Slovenian: 24.-27. aprila
English: Applications for initial evaluation (human medicines)
Slovenian: Vloge za začetno oceno (Zdravila za uporabo v humani medicini)
English: 2 As authorised by the Budgetary Authority and adjusted by the Management Board on 15 December 2005.
Slovenian: 2 Proračunski organ odobril in upravni odbor prilagodil 15. decembra 2005.
English: Arbitration and Community referrals to EMEA (Human medicines)
Slovenian: Arbitraža in zadeve, ki jih Skupnosti predloži EMEA (Zdravila za uporabo v humani medicini)
English: 13-16 November
Slovenian: 13.-16. novembra
English: The Agency also expects an increase in the number of scientific-advice requests for medicinal products for veterinary use, given the Management Board's decision to extend the period for free scientific advice for products for minor uses and minor species for a further period of 12 months.
Slovenian: Glede na to, da je upravni odbor sprejel odločitev o podaljšanju roka za zastonj znanstveno svetovanje za izdelke za manj pomembne uporabe in vrste še za 12 mesecev, Agencija pričakuje tudi povečanje števila zahtevkov za znanstveno svetovanje za zdravila za veterinarsko uporabo.
English: CHAPTER 2 MEDICINES FOR HUMAN AND VETERINARY USE
Slovenian: POGLAVJE 2 ZDRAVILA ZA UPORABO V HUMANI MEDICINI IN VETERINARSKA ZDRAVILA 10
English: 3-5 October
Slovenian: 3.-5. oktobra
English: 1 As authorised by the Budgetary Authority and adjusted by the Management Board on 15 December 2005.
Slovenian: 1 Proračunski organ odobril in upravni odbor prilagodil 15. decembra 2005.
English: 11-14 December
Slovenian: 11.-14. decembra
English: 16-19 October
Slovenian: 16.-19. oktobra
English: The Agency's mandate to provide opinions on medicinal products intended for use exclusively in markets outside the EU (cooperation with the WHO) will have an impact on the scope of the certification scheme.
Slovenian: Na področje uporabe programa izdajanja potrdila bo vplivala naloga Agencije, da zagotavlja mnenja o zdravilih, namenjenih za uporabo samo na trgih zunaj EU (sodelovanje z WHO).
English: 11-13 July
Slovenian: 11.-13. julija
English: 7-9 February
Slovenian: 7.-9. februarja
English: 14-16 February
Slovenian: 14.-16. februarja
English: 20-23 February
Slovenian: 20.-23. februarja
English: EMEA structure
Slovenian: Organizacijska shema EMEA
English: 10-12 October
Slovenian: 10.-12. oktobra
English: 14-16 March
Slovenian: 14.-16. marca
English: CHAPTER 1 EMEA IN THE EUROPEAN SYSTEM
Slovenian: Uvod izvršnega direktorja POGLAVJE 1 EMEA V EVROPSKEM SISTEMU
English: In addition, reviews of RMPs (including risk-minimisation measures and other pharmacovigilance activities) to identify known and potential risks with the medicinal product will be required for some variations and line extensions which result in a significant change in a marketing authorisation.
Slovenian: Poleg tega se bodo za nekatere spremembe ali razširitve indikacij, ki pomembno spremenijo dovoljenje za promet, zahtevali pregledi načrtov za obvladovanje tveganja (vključno z ukrepi za zmanjševanje tveganja in drugimi dejavnostmi farmakovigilance), s katerimi bi opredelili znana in možna tveganja pri določenem zdravilu.
English: medicinal products for human use
Slovenian: zdravila za uporabo v humani medicini
English: • by email request to info@emea.eu.int
Slovenian: • na podlagi zahtevka, ki ga pošljete na e-naslov info@emea.eu.int
English: 6-7 September
Slovenian: 6.-7. septembra
English: Total Title 3
Slovenian: Naslov 3 skupaj
English: 7-9 March
Slovenian: 7.-9. marca
English: Orphan medicinal products for human use
Slovenian: Zdravila sirote za uporabo v humani medicini
English: 12-13 July
Slovenian: 12.-13. julija
English: Its ability to address and manage safety issues has now been strengthened, through provisions in the new legislation and the adoption of the Agency's long-term strategy.
Slovenian: Zdaj, po sprejetju novih zakonodajnih določb in dolgoročne strategije Agencije, je tako bolj sposobna obravnavati in obvladovati vprašanja varnosti.
English: 5-7 December
Slovenian: 5.-7. decembra
English: 20-22 June
Slovenian: 20.-22. junija
English: Applications received/forecast (Input)
Slovenian: Prejete/predvidene vloge (Vhodni podatek)
English: 12-14 September
Slovenian: 12.-14. septembra
English: Work within the network to establish an EU communications strategy; Work to ensure availability for the Agency of the highest-quality expertise at EU level for evaluation of medicines and for monitoring and assessing their safety; Establish an inventory of available scientific expertise in the European medicines network; identify and complement insufficient expertise and plan for succession of established expertise; Develop an EU competence-development strategy and strengthen competence development at EU level.
Slovenian: oblikovanje seznama razpoložljivega znanstvenega strokovnega znanja in izkušenj v Evropski mreži zdravil; določitev in dopolnitev nezadostnega strokovnega znanja in izkušenj ter načrtovanje prevzema uveljavljenega strokovnega znanja in izkušenj;
English: 5-7 September
Slovenian: 5.-7. septembra
English: Tuesday 19 December
Slovenian: Četrtek, 8. junija torek, 19. decembra
English: Type-II (clinical) variations
Slovenian: Razširitev indikacij (Klinične) spremembe tipa II (Kakovostne) spremembe tipa II Spremembe tipa IB Spremembe tipa IA
English: E-mail: silvia.domingo@emea.eu.int
Slovenian: E-naslov: silvia.domingo@emea.eu.int Za vprašanja o potrdilih VAMF
English: Annex 4 Management Board and scientific committee meeting dates in 2006 Annex 5 EMEA contact points
Slovenian: Priloga 2 Načrt delovnih mest EMEA za obdobje 2004-2006 Priloga 3 Pregled prihodkov in odhodkov za obdobje 2004-2006 Priloga 4 Datumi sestankov upravnega odbora in znanstvenega odbora v letu 2006 Priloga 5 Kontaktne osebe EMEA
English: TEMPORARY POSTS
Slovenian: ZAČASNA DELOVNA MESTA Zasedenost na dan
English: 12-14 December
Slovenian: 12.-14. decembra
English: Applications received/forecast (human medicines)
Slovenian: Prejete/predvidene vloge (Zdravila za uporabo v humani medicini)
English: Out of hours telephone: (44-7880) 55 06 97
Slovenian: Faks: (44-20) 74 18 85 90 Telefon izven uradnih ur:(44-7880) 55 06 97
English: POST-AUTHORISATION EVALUATION OF MEDICINES FOR
Slovenian: VREDNOTENJE ZDRAVIL ZA UPORABO V HUMANI MEDICINI PO IZDAJI DOVOLJENJA ZA PROMET
English: medicinal products for veterinary use
Slovenian: veterinarska zdravila
English: Applications received/forecast (veterinary medicines)
Slovenian: Prejete/predvidene vloge (Veterinarska zdravila)
English: Annex 5 EMEA contact points
Slovenian: Kontaktne osebe EMEA
English: Herbal medicinal products for human use
Slovenian: Zdravila rastlinskega izvora za uporabo v humani medicini
English: Do not stop taking this medicine, even if you are feeling well (unless your doctor tells you to do so).
Slovenian: Ne prenehajte jemati tega zdravila, tudi če se počutute dobro (razen če vam tako naroči zdravnik).
English: If it is almost time for your next dose you should simply take the next tablet at the usual time.
Slovenian: Če pa je že skoraj čas za naslednji odmerek, preprosto vzemite samo naslednji odmerek ob običajnem času.
English: Your doctor will normally advise you to stop taking Riprazo HCT before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Riprazo HCT.
Slovenian: Zdravnik vam bo praviloma svetoval, da prenehate z jemanjem zdravila Riprazo HCT še preden zanosite oziroma takoj, ko ugotovite, da ste noseči in vam bo svetoval jemanje drugega zdravila namesto zdravila Riprazo HCT.
English: No clinically relevant interactions have been identified.
Slovenian: Pri teh učinkovinah niso ugotovili nobenih klinično pomembnih interakcij.
English: Riprazo HCT may have been prescribed to you because your previous treatment did not lower your blood pressure enough.
Slovenian: Zdravilo Riprazo HCT so vam morda predpisali zato, ker vaše predhodno zdravljenje ni dovolj znižalo krvnega tlaka.
English: The safety of Riprazo HCT has been evaluated in 9 clinical trials with more than 3,900 patients, including over 700 treated for over 6 months, and 190 for over 1 year.
Slovenian: Varnost zdravila Riprazo HCT so ocenjevali v 9 kliničnih preskušanjih z več kot 3.900 bolniki, med katerimi je bilo več kot 700 bolnikov zdravljenih več kot 6 mesecev, 190 pa več kot 1 leto.
English: Hydrochlorothiazide has been extensively prescribed for many years, frequently in higher doses than those contained in Riprazo HCT.
Slovenian: Hidroklortiazid intenzivno predpisujejo že mnogo let, pogosto v precej višjih odmerkih, kot je prisoten v zdravilu Riprazo HCT.
English: The use of Riprazo HCT in children and adolescents up to 18 years of age is not recommended.
Slovenian: Uporaba zdravila Riprazo HCT pri otrocih in mladostnikih do 18. leta starosti ni priporočena.
English: The combination of these substances with complementary mechanisms of action provides an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone.
Slovenian: Kombinacija teh dveh snovi s komplementarnimi mehanizmi delovanja omogoča aditiven antihipertenzivni učinek, ki zniža krvni tlak v večji meri kot vsaka od posameznih sestavin samostojno.
English: It is suitable for people with coeliac disease.
Slovenian: Primerno je za ljudi s celiakijo.
English: These could be symptoms of an increase of pressure in your eye and can happen within hours to weeks of taking Riprazo HCT.
Slovenian: To sta lahko simptoma povečanega tlaka v očesu in se lahko pojavita v nekaj urah do nekaj tednih jemanja zdravila Riprazo HCT.
English: Packs containing 90 (3x30), 98 (2x49) or 280 (20x14) tablets are multi-packs.
Slovenian: Pakiranja, ki vsebujejo 90 (3x30), 98 (2x49) ali 280 (20x14) tablet, so skupna pakiranja.
English: WHAT RIPRAZO HCT IS AND WHAT IT IS USED FOR
Slovenian: KAJ JE ZDRAVILO RIPRAZO HCT IN ZA KAJ GA UPORABLJAMO
English: No specific clinical studies have been performed with this combination, therefore Riprazo HCT should not be used during the first trimester of pregnancy or in women planning to become pregnant and is contraindicated during the second and third trimesters (see section 4.3).
Slovenian: S to kombinacijo niso opravili posebnih kliničnih študij, zato zdravila Riprazo HCT ne smete uporabljati v prvem trimesečju nosečnosti oziroma pri ženskah, ki načrtujejo nosečnost, poleg tega je kontraindiciran v drugem in tretjem trimesečju nosečnosti (glejte poglavje 4.3).
English: Riprazo HCT is used to treat high blood pressure.
Slovenian: Zdravilo Riprazo HCT je namenjeno zdravljenju visokega krvnega tlaka.
English: Do not use Riprazo HCT after the expiry date which is stated on the carton.
Slovenian: Zdravila Riprazo HCT ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli.
English: Contains lactose and wheat starch.
Slovenian: Vsebuje laktozo in pšenični škrob.
English: Patients with wheat allergy (different from coeliac disease) should not take this medicine.
Slovenian: Pacienti z alergijo na pšenico (ki je drugačna od celiakije) ne smejo jemati tega zdravila.
English: Take special care with Riprazo HCT - if you have impaired kidney function, your doctor will carefully consider whether Riprazo HCT
Slovenian: Bodite posebno pozorni pri uporabi zdravila Riprazo HCT - če imate okvarjeno delovanje ledvic bo vaš zdravnik pozorno premislil, ali je zdravilo Riprazo
English: If angioedema occurs, Riprazo HCT should be promptly discontinued and appropriate therapy and monitoring provided until complete and sustained resolution of signs and symptoms has occurred.
Slovenian: Če pride do angioedema, je treba zdravljenje z zdravilom Riprazo HCT takoj prekiniti in poskrbeti za ustrezno zdravljenje in spremljanje bolnika, dokler znaki in simptomi niso v celoti in trajno odpravljeni.
English: These reduce the amount of angiotensin II the body can make.
Slovenian: Ta zdravila zmanjšujejo količino angiotenzina II, ki nastaja v telesu.
English: Riprazo HCT is unlikely to affect the ability to drive and use machines.
Slovenian: Ni verjetno, da bi zdravilo Riprazo HCT vplivalo na sposobnost vožnje in upravljanja s stroji.
English: Pharmacotherapeutic group: Renin inhibitor (aliskiren) combinations with diuretics (hydrochlorothiazide), ATC code: C09XA52
Slovenian: Farmakoterapevtska skupina: kombinacije zaviralca renina (aliskirena) z diuretiki (s hidroklorotiazidom), oznaka ATC: C09XA52
English: The recommended dose of Riprazo HCT is one tablet per day.
Slovenian: Priporočeni odmerek zdravila Riprazo HCT je ena tableta na dan.
English: Important information about some of the ingredients of Riprazo HCT Riprazo HCT contains lactose (milk sugar).
Slovenian: Pomembne informacije o nekaterih sestavinah zdravila Riprazo HCT Zdravilo Riprazo HCT vsebuje laktozo (mlečni sladkor).
English: Food interactions: Meals with a high fat content have been shown to reduce the absorption of aliskiren substantially.
Slovenian: Medsebojno delovanje s hrano: Pokazalo se je, da obroki z veliko vsebnostjo maščob bistveno zmanjšajo absorpcijo aliskirena.
English: Conversely, it is anticipated that prokinetic substances such as cisapride may decrease the bioavailability of thiazidetype diuretics.
Slovenian: Nasprotno pa predvidevajo, da prokinetične snovi, kot je cisaprid, lahko zmanjšajo biološko uporabnost diuretikov tiazidnega tipa.
English: Warfarin: The effects of aliskiren on warfarin pharmacokinetics have not been evaluated.
Slovenian: Varfarin: Učinkov aliskirena na farmakokinetične lastnosti varfarina niso ocenjevali.
English: Aliskiren should be used with caution in patients with serious congestive heart failure (New York Heart Association (NYHA) functional class III-IV).
Slovenian: Previdnost je potrebna pri uporabi aliskirena pri bolnikih z resnim kongestivnim srčnim popuščanjem (funkcijskih razredov III-IV po klasifikaciji Newyorškega združenja za srce (New York Heart Association (NYHA)).
English: If you take more Riprazo HCT than you should If you have accidentally taken too many Riprazo HCT tablets, talk to a doctor immediately.
Slovenian: Če ste vzeli večji odmerek zdravila Riprazo HCT, kot bi smeli Če ste pomotoma vzeli več tablet zdravila Riprazo HCT, kot bi smeli, se takoj posvetujte z zdravnikom.
English: Riprazo HCT is not recommended during pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Slovenian: Jemanje zdravila Riprazo HCT med nosečnostjo ni priporočljivo, ko pa ste noseči več kot 3 mesece, ga ne smete jemati, ker lahko uporaba po tretjem mesecu nosečnosti povzroči resno škodo vašemu otroku.
English: • Worsening of the diabetic metabolic state
Slovenian: • poslabšanje metaboličnega stanja pri sladkorni bolezni,
English: You may need to stop Riprazo HCT.
Slovenian: Morda boste morali prenehati z jemanjem zdravila Riprazo HCT.
English: Pressor amines (e.g. noradrenaline, adrenaline): Hydrochlorothiazide may reduce the response to pressor amines such as noradrenaline.
Slovenian: Presorski amini (npr. noradrenalin, adrenalin): Hidroklorotiazid lahko zmanjša odziv na presorske amine, kot je noradrenalin.
English: What Riprazo HCT is and what it is used for Before you take Riprazo HCT How to take Riprazo HCT Possible side effects
Slovenian: Kaj je zdravilo Riprazo HCT in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Riprazo HCT Kako jemati zdravilo Riprazo HCT Možni neželeni učinki
English: BLISTERS (PVC/PCTFE OR PA/ALU/PVC) BLISTER (CALENDAR) (PVC/PCTFE OR PA/ALU/PVC)
Slovenian: PRETISNI OMOT (PVC/PCTFE ALI PA/ALU/PVC) PRETISNI OMOT (KOLEDARSKO PAKIRANJE) (PVC/PCTFE ALI PA/ALU/PVC)
English: • Low blood pressure
Slovenian: • nizek krvni tlak.
English: If this is the case, your doctor will tell you how to switch from that treatment to Riprazo HCT.
Slovenian: V tem primeru vam bo zdravnik povedal, kako preiti s predhodnega zdravljenja na uporabo zdravila Riprazo HCT.
English: There is no evidence that Riprazo HCT would reduce or prevent diuretic-induced hyponatraemia.
Slovenian: Ni dokazov, da bi zdravilo Riprazo HCT zmanjševalo ali preprečevalo hiponatriemijo, ki jo sicer povzročajo diuretiki.
English: Respiratory distress (including pneumonitis and pulmonary oedema)
Slovenian: dihalna stiska (vključno s pljučnico in pljučnim edemom)
English: Multi-packs containing 90, 98 or 280 tablets.
Slovenian: Skupna pakiranja vsebujejo po 90, 98 ali 280 tablet.
English: Do not take Riprazo HCT - if you are allergic (hypersensitive) to aliskiren or hydrochlorothiazide, to sulphonamide-derived medicines (medicines used to treat chest or urinary infections) or to any of the other ingredients of Riprazo HCT.
Slovenian: Ne jemljite zdravila Riprazo HCT - če ste alergični (preobčutljivi) na aliskiren ali hidroklorotiazid, na sulfonamidna zdravila (zdravila za zdravljenje okužb prsnega koša ali sečil) ali na katerokoli sestavino zdravila Riprazo HCT.
English: No pharmacokinetic data are available in the paediatric population.
Slovenian: Za pediatrično poulacijo ni na voljo nobenih farmakokinetičnih podatkov.
English: Riprazo HCT should be taken with a light meal once a day, preferably at the same time each day.
Slovenian: Zdravilo Riprazo HCT je treba jemati z lahkim obrokom enkrat na dan, najbolje vsak dan ob istem času.
English: Alcohol, barbiturates or narcotics: Concomitant administration of thiazide diuretics with subtances that also have a blood pressure lowering effect (e.g. by reducing sympathetic central nervous system activity or direct vasodilatation) may potentiate orthostatic hypotension.
Slovenian: Alkohol,barbiturati ali narkotiki: Sočasna uporaba tiazidnih diuretikov in snovi, ki prav tako znižujejo krvni tlak (na primer z zmanjševanjem aktivnosti simpatičnega centralnega živčevja ali z direktno vazodilatacijo) lahko okrepi ortostatsko hipotenzijo.
English: As with any antihypertensive agent, excessive reduction of blood pressure in patients with ischaemic cardiopathy or ischaemic cardiovascular disease could result in a myocardial infarction or stroke.
Slovenian: Tako kot pri uporabi kateregakoli antihipertenzivnega zdravila lahko prekomerno znižanje krvnega tlaka pri bolnikih z ishemično boleznijo srca ali ishemično kardiovaskularno boleznijo povzroči miokardni infarkt ali možgansko kap.
English: Multi-packs containing 280 tablets.
Slovenian: Skupna pakiranja vsebujejo po 280 tablet.
English: Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product.
Slovenian: Bolniki z redkimi prirojenimi motnjami kot so intoleranca za galaktozo, laponska oblika zmanjšane aktivnosti laktaze ali malabsorpcija glukoze/galaktoze, ne smejo jemati tega zdravila.
English: Therefore the use of Riprazo HCT with an NSAID requires caution, especially in elderly patients.
Slovenian: Zato je pri uporabi zdravila Riprazo HCT z nesteroidnimi protivnetnimi zdravili, posebno pri starejših bolnikih, potrebna previdnost.
English: As for any combination of two active substances, side effects associated with each individual component cannot be excluded.
Slovenian: Kot pri uporabi katerekoli kombinacije dveh zdravilnih učinkovin, ni mogoče izključiti možnosti neželenih učinkov, ki so povezani s posameznimi sestavinami.
English: Not all pack sizes or strengths may be available in your country.
Slovenian: Na vašem trgu morda ni vseh navedenih pakiranj ali jakosti.
English: Like all medicines, Riprazo HCT can cause side effects, although not everybody gets them.
Slovenian: Kot vsa zdravila ima lahko tudi zdravilo Riprazo HCT neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
English: If any of the above applies to you, do not take Riprazo HCT and talk to your doctor.
Slovenian: Če kaj od navedenega velja za vas, ne jemljite zdravila Riprazo HCT in se posvetujte s svojim zdravnikom.
English: Not known:
Slovenian: neznana:
English: The use of Riprazo HCT during breast-feeding is not recommended.
Slovenian: Uporaba zdravila Riprazo HCT med dojenjem ni priporočena.
English: Riprazo HCT contains lactose.
Slovenian: Zdravilo Riprazo HCT vsebuje laktozo.
English: 56 film-coated tablets (56x1; perforated unit dose blister)
Slovenian: 56 filmsko obloženih tablet (56x1; perforirani pretisni omoti za
English: If blood pressure remains uncontrolled after 2-4 weeks of therapy, the dose may be titrated up to a maximum of Riprazo HCT 300 mg/25 mg daily.
Slovenian: Če po 2-4 tednih zdravljenja krvni tlak še vedno ni urejen, je odmerek mogoče zvišati do največ 300 mg/25 mg zdravila Riprazo HCT dnevno.
English: Aliskiren/hydrochlorothiazide Over 3,900 hypertensive patients received Riprazo HCT once daily in clinical trials.
Slovenian: V kliničnih preskušanjih je več kot 3.900 hipertenzivnih bolnikov prejemalo zdravilo Riprazo HCT enkrat dnevno.
English: Medicinal products that could induce torsades de pointes: Due to the risk of hypokalaemia, hydrochlorothiazide should be administered with caution when associated with medicinal products that could induce torsades de pointes, in particular Class Ia and Class III antiarrhythmics and some antipsychotics.
Slovenian: Zdravila, ki lahko sprožijo torsades de pointes: Zaradi nevarnosti hipokaliemije je potrebna previdnost pri uporabi hidroklorotiazida v kombinaciji z zdravili, ki lahko sprožijo torsades de pointes, zlasti z antiaritmiki skupin Ia in III in z nekaterimi antipsihotiki.
English: A switch to a suitable alternative treatment should be carried out in advance of a planned pregnancy.
Slovenian: Pried načrtovanjem nosečnosti je treba preiti na ustrezno alternativno zdravljenje.